JANET SADLER: Open Payments
NPI 1972262681 · MIDDLETOWN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 32 payments from 11 companies in 2025. Trend: 2023 $1,219 · 2024 $1,716 · 2025 $701
Food & beverage: $701
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $149 |
| Novartis Pharmaceuticals Corporation | 5 | $145 |
| AstraZeneca Pharmaceuticals LP | 5 | $102 |
| Amgen Inc. | 4 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $55 |
| Alnylam Pharmaceuticals Inc. | 1 | $39 |
| Abbott Laboratories | 1 | $30 |
| BridgeBio Pharma, Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $26 |
Products named: LEQVIO, ELIQUIS, Repatha, FARXIGA, Kerendia, VYNDAQEL, AVEIR, Attruby.
Industry payments across CT — which companies pay providers there.
